Invention Grant
- Patent Title: Sulfonamide compound or salt thereof
- Patent Title (中): 磺酰胺化合物或其盐
-
Application No.: US12297445Application Date: 2007-08-09
-
Publication No.: US07973078B2Publication Date: 2011-07-05
- Inventor: Hideki Kubota , Susumu Toda , Issei Tsukamoto , Yuta Fukuda , Ryutaro Wakayama , Kazuki Ono , Toru Watanabe , Hidenori Azami
- Applicant: Hideki Kubota , Susumu Toda , Issei Tsukamoto , Yuta Fukuda , Ryutaro Wakayama , Kazuki Ono , Toru Watanabe , Hidenori Azami
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2006-218923 20060810
- International Application: PCT/JP2007/065613 WO 20070809
- International Announcement: WO2008/018544 WO 20080214
- Main IPC: C07C303/00
- IPC: C07C303/00 ; A01N41/06
Abstract:
A compound that can be used as an agent for treating a disease associated with an EP1 receptor, in particular a lower urinary tract symptom. It was confirmed that a sulfonamide compound having an amide structure and characterized by a chemical structure in which a carbon atom in the amide bonds to the N atom in sulfonamide through lower alkylene, or a salt thereof, has a potent EP1 receptor antagonistic activity, accomplishing the present invention. Since the sulfonamide compound of the present invention or a pharmaceutically acceptable salt thereof has a potent EP1 receptor antagonistic activity, it is useful as an agent for treating a disease associated with an EP1 receptor, in particular, a lower urinary tract symptom.
Public/Granted literature
- US20090312328A1 SULFONAMIDE COMPOUND OR SALT THEREOF Public/Granted day:2009-12-17
Information query
